Deaths and disability from natalizumab are no longer tolerable: No - (they can be avoided)
Research output: Contribution to journal › Journal article › Research › peer-review
Original language | English |
---|---|
Journal | Multiple Sclerosis |
Volume | 18 |
Issue number | 8 |
Pages (from-to) | 1070-2 |
Number of pages | 3 |
ISSN | 1352-4585 |
DOIs | |
Publication status | Published - 2012 |
ID: 48584462